Avestar Capital, LLC Dr Reddys Laboratories LTD Transaction History

Avestar Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$34.82 - $39.26 $696 - $785	-20 Closed	0 $0
Q2 2019 Aug 06, 2019	BUY	$36.05 - $42.76 $324 - $384	9 Added 81.82%	20 $0
Q4 2018 Jan 25, 2019	BUY	$31.89 - $38.44 $350 - $422	11 New	11 $0
Q3 2018 Oct 23, 2018	SELL	$29.25 - $36.73 $292 - $367	-10 Closed	0 $0
Q2 2018 Aug 10, 2018	BUY	$28.49 - $35.06 $284 - $350	10 New	10 $0

265

107M

71K

22.5K

Ticker RDY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 166,028,992
Market Cap $2.25B
Description
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...

Get notified when there are updates to the investment portfolio of Avestar Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Avestar Capital, LLC with notifications on news.